APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Injectable

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Contraceptive Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173980750321 December 2025188 pages

Choose your research edition.

Industry ResearchContraceptive Injectable Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Injectable Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Contraceptive Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Injectable Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Injectable Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Injectable market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contraceptive Injectable include Janssen Pharmaceuticals, Inc., Pfizer Inc., China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Bayer AG, Veru, Inc., Organon Group Of Companies, Church & Dwight, Agile Therapeutics and Afaxys, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Injectable market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Injectable and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Injectable sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Injectable market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Injectable Segment by Company

Janssen Pharmaceuticals, Inc.

Pfizer Inc.

China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

Bayer AG

Veru, Inc.

Organon Group Of Companies

Church & Dwight

Agile Therapeutics

Afaxys, Inc.

Contraceptive Injectable Segment by Type

Long-Acting Contraception

Short-Acting Contraception

Contraceptive Injectable Segment by Application

Male

Female

Contraceptive Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Injectable market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contraceptive Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contraceptive Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Injectable Industry Trends Table 2. Contraceptive Injectable Industry Drivers Table 3. Contraceptive Injectable Industry Opportunities and Challenges Table 4. Contraceptive Injectable Industry Restraints Table 5. Global Contraceptive Injectable Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contraceptive Injectable Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contraceptive Injectable Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Contraceptive Injectable Sales Market Share by Manufacturers Table 9. Global Contraceptive Injectable Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Contraceptive Injectable Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contraceptive Injectable Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contraceptive Injectable Manufacturers, Product Type & Application Table 13. Global Contraceptive Injectable Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Injectable by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Long-Acting Contraception Table 17. Major Manufacturers of Short-Acting Contraception Table 18. Global Contraceptive Injectable Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 20. Global Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 21. Global Contraceptive Injectable Sales Market Share by Type (2021-2026) Table 22. Global Contraceptive Injectable Sales Market Share by Type (2027-2032) Table 23. Global Contraceptive Injectable Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Contraceptive Injectable Revenue by Type (2021-2026) & (k units) Table 25. Global Contraceptive Injectable Revenue by Type (2027-2032) & (k units) Table 26. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026) Table 27. Global Contraceptive Injectable Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Male Table 29. Major Manufacturers of Female Table 30. Global Contraceptive Injectable Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 32. Global Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 33. Global Contraceptive Injectable Sales Market Share by Application (2021-2026) Table 34. Global Contraceptive Injectable Sales Market Share by Application (2027-2032) Table 35. Global Contraceptive Injectable Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Contraceptive Injectable Revenue by Application (2021-2026) & (k units) Table 37. Global Contraceptive Injectable Revenue by Application (2027-2032) & (k units) Table 38. Global Contraceptive Injectable Revenue Market Share by Application (2021-2026) Table 39. Global Contraceptive Injectable Revenue Market Share by Application (2027-2032) Table 40. Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Contraceptive Injectable Sales by Region (2021-2026) & (k units) Table 42. Global Contraceptive Injectable Sales Market Share by Region (2021-2026) Table 43. Global Contraceptive Injectable Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Contraceptive Injectable Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 47. North America Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 48. Europe Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 50. Europe Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 57. Global Contraceptive Injectable Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Contraceptive Injectable Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Contraceptive Injectable Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Contraceptive Injectable Revenue Market Share by Region (2021-2026) Table 61. Global Contraceptive Injectable Revenue Market Share by Region (2027-2032) Table 62. Janssen Pharmaceuticals, Inc. Company Information Table 63. Janssen Pharmaceuticals, Inc. Business Overview Table 64. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio Table 66. Janssen Pharmaceuticals, Inc. Recent Development Table 67. Pfizer Inc. Company Information Table 68. Pfizer Inc. Business Overview Table 69. Pfizer Inc. Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Pfizer Inc. Contraceptive Injectable Product Portfolio Table 71. Pfizer Inc. Recent Development Table 72. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information Table 73. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview Table 74. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio Table 76. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Development Table 77. Bayer AG Company Information Table 78. Bayer AG Business Overview Table 79. Bayer AG Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bayer AG Contraceptive Injectable Product Portfolio Table 81. Bayer AG Recent Development Table 82. Veru, Inc. Company Information Table 83. Veru, Inc. Business Overview Table 84. Veru, Inc. Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Veru, Inc. Contraceptive Injectable Product Portfolio Table 86. Veru, Inc. Recent Development Table 87. Organon Group Of Companies Company Information Table 88. Organon Group Of Companies Business Overview Table 89. Organon Group Of Companies Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Organon Group Of Companies Contraceptive Injectable Product Portfolio Table 91. Organon Group Of Companies Recent Development Table 92. Church & Dwight Company Information Table 93. Church & Dwight Business Overview Table 94. Church & Dwight Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Church & Dwight Contraceptive Injectable Product Portfolio Table 96. Church & Dwight Recent Development Table 97. Agile Therapeutics Company Information Table 98. Agile Therapeutics Business Overview Table 99. Agile Therapeutics Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Agile Therapeutics Contraceptive Injectable Product Portfolio Table 101. Agile Therapeutics Recent Development Table 102. Afaxys, Inc. Company Information Table 103. Afaxys, Inc. Business Overview Table 104. Afaxys, Inc. Contraceptive Injectable Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Afaxys, Inc. Contraceptive Injectable Product Portfolio Table 106. Afaxys, Inc. Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Contraceptive Injectable Distributors List Table 110. Contraceptive Injectable Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Contraceptive Injectable Product Image Figure 2. Global Contraceptive Injectable Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Injectable Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Injectable Sales (2021-2032) & (k units) Figure 5. Global Contraceptive Injectable Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Contraceptive Injectable Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Long-Acting Contraception Image Figure 9. Short-Acting Contraception Image Figure 10. Global Contraceptive Injectable Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Contraceptive Injectable Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Contraceptive Injectable Sales Market Share by Type (2021-2032) Figure 13. Global Contraceptive Injectable Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Contraceptive Injectable Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Contraceptive Injectable Revenue Market Share by Type (2021-2032) Figure 16. Male Image Figure 17. Female Image Figure 18. Global Contraceptive Injectable Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Contraceptive Injectable Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Contraceptive Injectable Sales Market Share by Application (2021-2032) Figure 21. Global Contraceptive Injectable Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Contraceptive Injectable Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Contraceptive Injectable Revenue Market Share by Application (2021-2032) Figure 24. North America Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Contraceptive Injectable Sales Market Share by Country (2021-2032) Figure 26. U.S. Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Contraceptive Injectable Sales Market Share by Country (2021-2032) Figure 31. Germany Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Contraceptive Injectable Sales Market Share by Country (2021-2032) Figure 38. China Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Contraceptive Injectable Sales Market Share by Country (2021-2032) Figure 46. Brazil Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Contraceptive Injectable Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Contraceptive Injectable Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Contraceptive Injectable Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Figure 57. North America Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Figure 59. Europe Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Contraceptive Injectable Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Contraceptive Injectable Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Long-Acting Contraception
  • Short-Acting Contraception
Applications
  • Male
  • Female
Companies covered
  • Janssen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  • Bayer AG
  • Veru, Inc.
  • Organon Group Of Companies
  • Church & Dwight
  • Agile Therapeutics
  • Afaxys, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contraceptive Injectable Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contraceptive Injectable Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contraceptive Injectable Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contraceptive Injectable Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contraceptive Injectable Market Dynamics
  1. 2.1 Contraceptive Injectable Industry Trends
  2. 2.2 Contraceptive Injectable Industry Drivers
  3. 2.3 Contraceptive Injectable Industry Opportunities and Challenges
  4. 2.4 Contraceptive Injectable Industry Restraints
3 Contraceptive Injectable Market by Manufacturers
  1. 3.1 Global Contraceptive Injectable Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contraceptive Injectable Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contraceptive Injectable Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contraceptive Injectable Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptive Injectable Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contraceptive Injectable Manufacturers, Product Type & Application
  7. 3.7 Global Contraceptive Injectable Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptive Injectable Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptive Injectable Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptive Injectable Tier 1, Tier 2, and Tier 3
4 Contraceptive Injectable Market by Type
  1. 4.1 Contraceptive Injectable Type Introduction
  2. 4.1.1 Long-Acting Contraception
  3. 4.1.2 Short-Acting Contraception
  4. 4.2 Global Contraceptive Injectable Sales by Type
  5. 4.2.1 Global Contraceptive Injectable Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Contraceptive Injectable Sales by Type (2021-2032)
  7. 4.2.3 Global Contraceptive Injectable Sales Market Share by Type (2021-2032)
  8. 4.3 Global Contraceptive Injectable Revenue by Type
  9. 4.3.1 Global Contraceptive Injectable Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Contraceptive Injectable Revenue by Type (2021-2032)
  11. 4.3.3 Global Contraceptive Injectable Revenue Market Share by Type (2021-2032)
5 Contraceptive Injectable Market by Application
  1. 5.1 Contraceptive Injectable Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Contraceptive Injectable Sales by Application
  5. 5.2.1 Global Contraceptive Injectable Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contraceptive Injectable Sales by Application (2021-2032)
  7. 5.2.3 Global Contraceptive Injectable Sales Market Share by Application (2021-2032)
  8. 5.3 Global Contraceptive Injectable Revenue by Application
  9. 5.3.1 Global Contraceptive Injectable Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contraceptive Injectable Revenue by Application (2021-2032)
  11. 5.3.3 Global Contraceptive Injectable Revenue Market Share by Application (2021-2032)
6 Global Contraceptive Injectable Sales by Region
  1. 6.1 Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Injectable Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Injectable Sales by Region (2021-2026)
  4. 6.2.2 Global Contraceptive Injectable Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contraceptive Injectable Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contraceptive Injectable Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contraceptive Injectable Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contraceptive Injectable Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contraceptive Injectable Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contraceptive Injectable Revenue by Region
  1. 7.1 Global Contraceptive Injectable Revenue by Region
  2. 7.1.1 Global Contraceptive Injectable Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contraceptive Injectable Revenue by Region (2021-2026)
  4. 7.1.3 Global Contraceptive Injectable Revenue by Region (2027-2032)
  5. 7.1.4 Global Contraceptive Injectable Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contraceptive Injectable Revenue (2021-2032)
  8. 7.2.2 North America Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contraceptive Injectable Revenue (2021-2032)
  11. 7.3.2 Europe Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contraceptive Injectable Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contraceptive Injectable Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contraceptive Injectable Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceuticals, Inc.
  2. 8.1.1 Janssen Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Janssen Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
  6. 8.1.5 Janssen Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  14. 8.3.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
  15. 8.3.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview
  16. 8.3.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
  18. 8.3.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments
  19. 8.4 Bayer AG
  20. 8.4.1 Bayer AG Company Information
  21. 8.4.2 Bayer AG Business Overview
  22. 8.4.3 Bayer AG Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer AG Contraceptive Injectable Product Portfolio
  24. 8.4.5 Bayer AG Recent Developments
  25. 8.5 Veru, Inc.
  26. 8.5.1 Veru, Inc. Company Information
  27. 8.5.2 Veru, Inc. Business Overview
  28. 8.5.3 Veru, Inc. Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Veru, Inc. Contraceptive Injectable Product Portfolio
  30. 8.5.5 Veru, Inc. Recent Developments
  31. 8.6 Organon Group Of Companies
  32. 8.6.1 Organon Group Of Companies Company Information
  33. 8.6.2 Organon Group Of Companies Business Overview
  34. 8.6.3 Organon Group Of Companies Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
  36. 8.6.5 Organon Group Of Companies Recent Developments
  37. 8.7 Church & Dwight
  38. 8.7.1 Church & Dwight Company Information
  39. 8.7.2 Church & Dwight Business Overview
  40. 8.7.3 Church & Dwight Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Church & Dwight Contraceptive Injectable Product Portfolio
  42. 8.7.5 Church & Dwight Recent Developments
  43. 8.8 Agile Therapeutics
  44. 8.8.1 Agile Therapeutics Company Information
  45. 8.8.2 Agile Therapeutics Business Overview
  46. 8.8.3 Agile Therapeutics Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
  48. 8.8.5 Agile Therapeutics Recent Developments
  49. 8.9 Afaxys, Inc.
  50. 8.9.1 Afaxys, Inc. Company Information
  51. 8.9.2 Afaxys, Inc. Business Overview
  52. 8.9.3 Afaxys, Inc. Contraceptive Injectable Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
  54. 8.9.5 Afaxys, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Injectable Value Chain Analysis
  2. 9.1.1 Contraceptive Injectable Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Injectable Production Mode & Process
  6. 9.2 Contraceptive Injectable Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Injectable Distributors
  9. 9.2.3 Contraceptive Injectable Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst